Gossamer Bio (GOSS) Operating Margin (2024 - 2026)
Gossamer Bio (GOSS) posted Operating Margin of 282.25% for Q2 2026, down 6.66% on a QoQ basis from 264.62% in Q1 2026, and up 5516.0% year-over-year from 5.03% in Q2 2025.
Powered by 
Analysis
Gossamer Bio (GOSS) Operating Margin (2024 - 2026) Analysis & Trends
Gossamer Bio has reported Operating Margin for 3 years, with the latest figure at 282.25% in Q2 2026.
- On a quarterly basis, Operating Margin rose 5516.0% year-over-year to 282.25% in Q2 2026; TTM through Jun 2026 was 311.7%, a 5021.0% increase from a year earlier, with the FY2025 full-year figure at 352.23%, down 29999.0% from the prior year.
- Operating Margin was 282.25% for Q2 2026 at Gossamer Bio, down from 264.62% in the prior quarter.
- The five-year high for Operating Margin was 54.35% in Q2 2024, with the low at 385.2% in Q4 2024.
- Average Operating Margin over 3 years is 294.25%, with a median of 337.41% recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Operating Margin sank 39176 bps in 2025, then surged 10761 bps in 2026.
- Over 3 years, Operating Margin stood at 385.2% in 2024, then climbed by 13 bps to 333.64% in 2025, then advanced by 15 bps to 282.25% in 2026.
- The last three Operating Margin figures came in at 282.25% (Q2 2026), 264.62% (Q1 2026), and 333.64% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 32.97% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 28.37% |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 9.03% |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 41.69% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 42.23% |
| 10 | Gossamer Bio | 51.23 Mn | -5.79 Mn | - | -282.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -282.25% |
| Mar 31, 2026 | -264.62% |
| Dec 31, 2025 | -333.64% |
| Sep 30, 2025 | -369.44% |
| Jun 30, 2025 | -337.41% |
| Mar 31, 2025 | -372.23% |
| Dec 31, 2024 | -385.20% |
| Sep 30, 2024 | -357.80% |
| Jun 30, 2024 | 54.35% |